program
|
Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back Date: August 1-2, 2009 Location: Berkeley Marina, CA Doubletree Hotel | ||
>> Sunday, August 2, 2009 | ||
| Sunday, August 2, 2009 | ||
| 7:00-8:00 am | Registration and Breakfast | |
| 8:00-9:40 am | Potential Therapeutic Options: Modulating the Pathway (15 mins. + 5 min. discussion) Moderator: Martin Zenker, MD | |
| 8:00-8:20 am | RAF Inhibitors | Gideon Bollag, PhD |
| 8:20-8:40 am | MEK Inhibitors | Judith Sebolt-Leopold, PhD |
| 8:40-9:00 am | Farnesyl Transferase Inhibitors | Jackson Gibbs, PhD |
| 9:00-9:20 am | Statins and the Ras Pathway Modulation | Alcino Silva, PhD |
| 9:20-9:40 am | Applications in Zebrafish Modeling | Elizabeth Patton, PhD |
| 9:40-9:55 am | Break | |
| 9:55-11:35 am | Moving Forward: Treating Genetic Syndromes (20 mins. + 5 min. discussion) Moderator: David Viskochil, MD, PhD | |
| 9:55-10:20 am | Tuberous Sclerosis | Elizabeth A. Thiele, MD, PhD |
| 10:20-10:45 am | Progeria | Mark W. Kieran, MD, PhD |
| 10:45-11:10 am | NF1 | Bruce R. Korf, MD, PhD |
| 11:10-11:35 am | Fragile X | Randi J. Hagerman, MD |
| 11:35-12:30 pm | Wrap-Up and Action Items Towards Clinical Trials Presenters and Moderators: Roger Packer, MD, Teri Melese, PhD Panelists: Chairs, Keynote, Moderators, NIH Participants Symposium Participants: Open Discussion | |
| 12:30 pm | ADJOURN and BOX LUNCH | |
| 1:15-4:00 pm | Ras Symposium NF Breakout session | |